Cargando…
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway
BRCA1 deficient breast cancers are aggressive and chemoresistant due, in part, to their enrichment of cancer stem cells that can be generated from carcinoma cells by an epithelial-mesenchymal transition (EMT). We previously discovered that BRCA1 deficiency activates EMT in mammary tumorigenesis. How...
Autores principales: | Bai, Feng, Wang, Chuying, Liu, Xiong, Hollern, Daniel, Liu, Shiqin, Fan, Cheng, Liu, Chang, Ren, Sijia, Herschkowitz, Jason I., Zhu, Wei-Guo, Pei, Xin-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891277/ https://www.ncbi.nlm.nih.gov/pubmed/35236825 http://dx.doi.org/10.1038/s41419-022-04646-7 |
Ejemplares similares
-
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
por: Bai, Feng, et al.
Publicado: (2021) -
Loss of function of GATA3 induces basal-like mammary tumors
por: Bai, Feng, et al.
Publicado: (2022) -
Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis
por: Liu, Xiong, et al.
Publicado: (2023) -
GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer
por: Bai, Feng, et al.
Publicado: (2021) -
p16(INK4a) suppresses BRCA1-deficient mammary tumorigenesis
por: Scott, Alexandria, et al.
Publicado: (2016)